Navigation Links
FDA Provides Clarity to Isis Regarding the Development Path for Mipomersen
Date:4/25/2008

f Executive Officer of Isis. "Conducting an outcome study in parallel with our continued evaluation of the effects of mipomersen on atherogenic lipids will allow us to submit a much stronger NDA for high risk patients. We are confident that mipomersen will bring benefit to patients with high cholesterol and remain committed to its development and commercialization."

"We are pleased that the FDA has given clear direction on what will be required for the approval of mipomersen, and has acknowledged its potential to help high risk patients whose needs are not being met by current therapies," said Henri A. Termeer, Genzyme's chairman and chief executive officer. "Having outcome data earlier on in the development process will be important to patients and serve to enhance the value of this treatment. We plan to engage in discussions with regulatory agencies in Europe and the rest of the world, and look forward to receiving their feedback."

ABOUT MIPOMERSEN

In early 2008, Isis and Genzyme announced that they had entered into a strategic alliance in which Genzyme will develop and commercialize mipomersen. Final contracts are still being negotiated and are expected to be completed this quarter.

Mipomersen is a second-generation antisense drug that reduces the production of apoB-100, a protein critical to the synthesis and transport of "bad" cholesterol. Cholesterol can be carried in the bloodstream in a variety of forms, with high-density lipoprotein, or HDL-cholesterol, being the good form, and low-density lipoproteins, or LDL-cholesterol, and very low-density lipoproteins, or VLDL-cholesterol, being bad forms directly involved in heart disease. Collectively lowering LDL-cholesterol, VLDL-cholesterol, and other bad forms of cholesterol are a key component in the prevention and management of cardiovascular disease.

Mipomersen is currently in phase 3 development for patients with homozygous familial hypercholesterolemia, a disease which crea
'/>"/>

SOURCE Genzyme Corp. and Isis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Study provides hope that some transplant patients could live free of antirejection drugs
2. Study provides hope that some transplant patients could live free of anti-rejection drugs
3. USAID Provides Additional Wildfire Assistance to Greece
4. LifeMasters Provides Tips for Maintaining a Healthy Blood Cholesterol Level
5. New knock-out gene model provides molecular clues to breast cancer
6. PreMD Provides Update on 510(k) Application for PREVU(x) POC
7. SIV infection of natural hosts provides new insights into HIV disease complexity
8. Microarray provides 3 genomic guides to breast cancer treatment decisions
9. Access Innovations Provides Support Services for Agis Network
10. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
11. Physical Therapist Provides Injury Analysis for Fantasy Football
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... WHAT: , Resistance to artemisinin, the main drug ... Asia, among the Plasmodium falciparum ( ... and is likely caused by a genetic mutation ... artemisinin-based combination therapyas opposed to a standard three-day ... cases, according to findings published today in the ...
(Date:7/30/2014)... 30, 2014 Good Neighbor Community ... an upcoming episode of Innovations with Ed Begley ... Dates and show times TBA. , In this ... Community Services’ vision to redefine the traditional approach ... dynamic services. Through passion, innovation, determination, excellence, and ...
(Date:7/30/2014)... Steven Reinberg HealthDay ... Each year in the United States, at least 2,000 Americans ... officials said Wednesday. Heat waves, heat stroke or sun ... reported between 2006 and 2010, according to the U.S. Centers ... -- a severe loss of body heat -- accounted for ...
(Date:7/30/2014)... HealthDay Reporter WEDNESDAY, July 30, 2014 (HealthDay ... excess pounds may want to team up with their child, ... a supervised behavioral modification program gained less weight than their ... average difference of about four pounds over two years). Their ... years, according to the study. "In a nutshell, we ...
(Date:7/30/2014)... happen in an instant: A small child pulls up on ... injured when the furniture tips over. "Every parent or ... and imagine what could tip over, fall off walls and ... a reality," Dr. Alex Rosenau, president of the American College ... Between 2009 and 2011, roughly 43,000 people ended up in ...
Breaking Medicine News(10 mins):Health News:Resistance to key malaria drug spreading at alarming rate in Southeast Asia 2Health News:Good Neighbor Community Services to be Featured in an Upcoming Episode of Innovations With Ed Begley, Jr. 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 2Health News: Extreme Weather Kills 2,000 in U.S. Each Year: CDC 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 2Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 3Health News:Make Kids' Weight Loss a Family Affair, Study Suggests 4Health News:Tip-Over Furniture Can Kill Kids 2
... was true for males tying the knot with younger females, study ... men seven to nine years their junior could be upping their ... with a significantly younger guy raises a woman,s risk of death ... 12 issue of Demography . , Not that marrying much ...
... years ago, scientists at Beth Israel Deaconess Medical Center ... the Akt molecular pathway, a popular target for cancer ... Akt1 was actively preventing cancer cells from ... was actually promoting breast cancer cell migration. And, indeed, ...
... 22q11 deletion syndrome (also known as DiGeorge syndrome) ... having an estimated incidence of at least one ... of severity but a multisystem impact, with symptoms ... endocrine abnormalities, cleft palate, gastrointestinal problems, and neuropsychiatric ...
... National ... was recently awarded certification from the Women’s Business Enterprise National Council (WBENC). ... San Diego, CA ... provider of water conservation and water management services , was ...
... ... extension option with Novation the leading health care supply contracting company for more than 25,000 ... and nearly 15,000 members of Provista, LLC. , ... Santa Clara (Vocus) May 14, 2010 -- Lumenis Ltd., a global leader ...
... out of ten patients who discontinued their overactive bladder (OAB) ... or they couldn,t tolerate it, according to research in the ... US researchers also discovered that smokers, men with enlarged prostates ... to stop taking prescription drugs for bladder problems. The ...
Cached Medicine News:Health News:Women Who Marry Younger Men May Die Earlier 2Health News:Study identifies 1 of the mechanisms behind breast cancer metastasis 2Health News:Without this protein, embryonic development halts 2Health News:National Water Services, Inc. Receives WBE Certification 2Health News:Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation 2Health News:Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation 3Health News:Lumenis Inc. Awarded a 3-year Dual Source Agreement with Novation 4Health News:Unmet expectations and smoking prove key factors in quitting bladder medication 2Health News:Unmet expectations and smoking prove key factors in quitting bladder medication 3
(Date:7/30/2014)... , July 30, 2014 ACCESS PHARMACEUTICALS, ... oncology supportive care, announced that its novel product for ... an article on OncLive.com titled, "Study Finds Mouth Rinse ... Dr. Steve Sonis , a leading expert in ... in the oncology community for evidence-based strategies for the ...
(Date:7/30/2014)... 30, 2014 /PRNewswire-iReach/ -- This is a professional ... Heparin sodium (CAS 9041-08-1) & calcium (CAS 37270-89-6) ... of Heparin sodium (CAS 9041-08-1) & calcium (CAS ... The report then explores global and China,s top ... (CAS 37270-89-6) listing their product specification, capacity, production ...
(Date:7/30/2014)... 30, 2014   Medical Equipment Solutions, Corp. ... a Department of Defense (US Army) contract valued at ... mobile MRI diagnostic machine and technical support staffing. As ... the Small Business Administration (SBA), Medical Equipment is proud ... the latest medical diagnostic equipment. The SBA 8-A certification ...
Breaking Medicine Technology:Access Pharmaceuticals Featured On OncLive.com 2Access Pharmaceuticals Featured On OncLive.com 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 2Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 3Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 4Heparin Sodium & Calcium Industry for Global and Chinese Markets Forecast to 2019 5Medical Equipment Solutions Corp. Awarded $2 Million contract To Service DoD 2
... Arena Pharmaceuticals, Inc. (Nasdaq: ARNA ) ... September 30, 2010. Arena also reported earlier today top-line ... and Lorcaserin for Overweight and Obesity Management in Diabetes ... results provide additional support for lorcaserin,s benefit-to-risk profile," said ...
... PLC Systems Inc. (OTC Bulletin Board: PLCSF ), ... that it had signed a definitive agreement to sell all ... Technologies Inc. (TSX: NDQ), a developer of real-time imaging systems ... exclusive United States distributor of PLC,s CO2 Heart Laser Systems ...
Cached Medicine Technology:Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 2Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 3Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 4Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 5Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 6Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 7Arena Pharmaceuticals Announces Third Quarter 2010 Financial Results and Reviews Recent Developments 8PLC Systems Signs TMR Asset Sale Agreement with Novadaq 2PLC Systems Signs TMR Asset Sale Agreement with Novadaq 3
... Laparoscopic Instruments incorporate a layered design unique ... and monitored to prevent stray electrosurgical burns ... by insulation failure or capacitive coupling; a ... built into all AEM Instruments provides a ...
... incorporate a layered design unique in the ... to prevent stray electrosurgical burns along the ... failure or capacitive coupling; a well-documented patient ... all AEM Instruments provides a neutral return ...
Disposable or reusable AEM cord for use with 5mm AEM Laparoscopic Instruments ....
... offers protection in three ... values with lightweight comfort ... quality. Lenses provide .75 ... are anti-reflection coated and ...
Medicine Products: